Summary
The effect of Pindolol on myocardial infarct size was studied in 10 open chest dogs. In each animal a sequential occlusion and reperfusion of 2 medium-sized branches of the left coronary artery was performed in the same heart. After occlusion and reperfusion of the control artery the initial dose of Pindolol (0.25 mg/kg body weight) was administered. Thereafter the test artery was occluded, followed by a maintenance dose of Pindolol (0.3 mg/kg body weight).
The drug caused a significant decrease in LVP and LV-dp/dt but no change in heart rate. MVO2 also decreased significantly. Regional myocardial blood flow was measured with the tracer microsphere method. Collateral flow in the perfusion area of the control artery was 11.2±5.9% and in the area of the test artery 10.0±4.4% of normal. No change in the endo/epi ratio as a result of treatment was observed.
The area of infarction (p-nitroblue tetrazolium-reaction) was divided by the area of perfusion (angiography). Infarct size, expressed as the percentage of the perfusion area. was 48.2±22.2% in the region of the control artery and 43.0±23.9% in the region of the test artery. The difference was statistically not significant.
Zusammenfassung
An 10 Hunden wurde die Wirkung von Pindolol auf die Hämodynamik, die regionale Myokardperfusion und die Infarktgröße nach experimentellem Koronarverschluß untersucht. An jedem Herzen wurden hintereinander 2 mittelgroße Äste der linken Koronararterie okkludiert. Nach Ligatur (90 Minuten) und Reperfusion der ersten Arterie (Kontrollarterie) wurde die Inititaldosis Pindolol (0,25 mg/kg Körpergewicht) infundiert. Während der Ligatur (90 Minuten) der zweiten Arterie (Testarterie) wurde eine Erhaltungsdosis Pindolol (0,3 mg/kg Körpergewicht/90 Minuten) infundiert. Der linke Ventrikeldruck, LV-dp/dt max., Aortendruck und Herzfrequenz wurden kontinuierlich gemessen. Der myokardiale Sauerstoffverbrauch wurde vom Computer (Bretschneider-Formel) während des Experimentes berechnet. Die Myokarddurchblutung wurde mit Hilfe der “tracer microsphere”-Technik bestimmt. Das Nekrosegebiet wurde makrohistochemisch (NBT-Färbung) und das Perfusionsgebiet der verschlossenen Arterie wurde angiographisch definiert. Die resultierende Infarktgröße wurde als Quotient aus Nekrose-und Perfusionsgebiet in Prozent ausgedrückt. Pindolol verursachte einen signifikanten Abfall des linken Ventrikeldrucks, und LV-dp/dt, die Herzfrequenz, änderte sich nicht. Der myokardiale Sauerstoffverbrauch nahm signifikant von 7,9±1,4 auf 6,9±1,9 ml/min×100g ab. Der Kollateralfluß betrug im Perfusionsgebiet der Kontrollarterie 11,2±5,9% und in dem der Testarterie 10,0±4,4% der Normaldurchblutung. Die Infarktgröße konnte durch Pindolol nicht beeinflußt werden, sie betrug nach Verschluß der Kontrollarterie 48,2±22,2% und nach Verschluß der Testarterie 43,0±23,9%.
Similar content being viewed by others
References
Maroko, P. R., E. Braunwald: Effects of metabolic and pharmacologic intervention on myocardial infarct size following coronary occlusion. Acta Med. Scand. (Suppl.)587, 125 (1976).
Maroko, P. R., J. K. Kjekshus, B. E. Sobel, T. Watanabe, J. W. Covell, J. Ross, Jr., E. Braunwald: Factors influencing infarct size following experimental coronary artery occlusion. Circulation43, 67 (1971).
Reimer, K. A., M. M. Rasmussen, R. B. Jennings: Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circ. Res.33, 353 (1973).
Schaper, W., und Jutta Schaper: Der experimentelle Infarkt. Verh. Dtsch. Ges. Herz-u. Kreislaufforschg.45, 1 (1979).
Haneda, T., T. Lee, W. Ganz: Metabolic effects of propranolol in the ischemic myocardium studied by regional sampling. Circulation48 (Suppl.)4, 174 (1973).
Schaper, W.: The Pathophysiology of Myocardial Perfusion, W. Schaper (ed.), Elsevier/North-Holland Biomedical Press (Amsterdam, New York, Oxford 1979).
Braunwald, E.: Control of myocardial oxygen consumption. Physiologic and clinical considerations. Am. J. Cardiol.27, 416 (1971).
Bretschneider, H. J.: Die hämodynamischen Determinanten des myokardialen Sauerstoffverbrauchs. In: Dengler, H. J. (Ed.): Die therapeutische Anwendung β-sympathikolytischer Stoffe, p. 45 Schattauer (Stuttgart-New York 1972).
Nachlas, M. M., T. K. Shnitka: Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Amer. J. Pathol.42, 379 (1963).
Schaper, W., H. Frenzel, W. Hort: Experimental coronary artery occlusion. I. Measurement of infarct size. Basic Res. Cardiol.74, 46 (1979).
Schaper, W., P. Levi, W. Flament, L. Gijpen: Myocardial steal produced by coronary vasodilatation in chronic coronary artery occlusion. Basic Res. Cardiol.68, 3 (1973).
Winkler, B.: The tracer microsphere method. In: The Pathophysiology of Myocardial Perfusion, W. Schaper (ed.), Elsevier/North-Holland Biomedical Press (Amsterdam, New York, Oxford 1979).
Lewi, P. J., W. K. A. Schaper, D. G. van Riel, W. W. Braet, L. H. Snoeckx, W. J. Flameng and R. F. Nuyens: The use of a minicomputer in cardiovascular pharmacology. Drug Res.23, 436 (1973).
Wollenberger, A., E.-G. Krause, and L. Shahab: Endogenous catecholamine mobilization and the shift to anaerobic energy production in the acutely ischemic myocardium. In International Symposium on the Coronary Circulation and Energetics of the Myocardium, pp. 200–219. G. Marchetti and B. Taccardi, Eds. S. Karger (Basel and New York 1967).
Fleckenstein, A.: Triangle27, 14 (1975).
Oliver, M. F.: Circulation45, 491 (1972).
Opie, L. H., F. T. Thandroyen, C. A. Müller, O. L. Bricknell: J. Mol. Cell. Cardiol.11, 1073 (1979).
Lubbe, W. F., O. L. Bricknell, T. Podzuweit, L. H. Opie: Cardiovasc. Res.10, 697 (1976).
Oliver, M. F., M. J. Rowe, M. L. Luxton, N. E. Miller, J. M. Weilson: Circulation53, 210 (1976).
Sowton, E.: Brit. med. J.1962/I, 84.
Opie, L. H.: Beta-Blockade: Metabolic effects in experimental myocardial infarction. Triangle19, 11 (1980).
Schaper, W., M. Hofmann, K.-D. Müller, K. Genth, M. Carl: Experimental occlusion of two small coronary arteries in the same heart. A new validation method for infarct size manipulation. Basic Res. Cardiol.74, 224 (1979).
Gross, G. J., M. M. Winbury: Beta adrenergic blockade on intramyocardial distribution of coronary blood flow. J. Pharmacol. exp. Ther.187, 451 (1973).
Berdeaux, A., C. P. Da Costa, M. Garmer, J. R. Boisser, J. F. Gindicelli: Beta adrenergic blockade, regional left ventricular blood flow and ST-segment elevation in canine experimental myocardial ischemia. J. of Pharmacol. and Exp. Therap.205, 646 (1978).
Gross, G. J., D. C. Warltier, H. F. Hardmann: Beneficial actions of N-dimethyl propranolol on myocardial oxygen balance and transmural perfusion gradients distal to a severe coronary artery stenosis in the canine heart. Circulation58, 663 (1978).
Becker, L. C., N. J. Fortuin, B. Pitt: Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ. Res.28, 263 (1971).
Waagstein, F., A. C. Hjalmarson: Double-bluid study of the effect of cardioselectiva β-blockade on chest pain in acute myocardial infarction. Acta Med. Scand. (Suppl.)587, 201 (1975).
Wilhelmsson, C., J. A. Vedin, L. Wilhelmsen, G. Tibblin, C. Werkö: Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet1974/II, 1157.
Fulton, W. F. M.: The coronary arteries. Saunders (1966).
Hofmann, M., Mechthild Hofmann, K. Genth, W. Schaper: The influence of reperfusion on infarct size after experimental coronary artery occlusion. Basic Res. Cardiol.75, 572 (1980).
Jennings, R. B., and K.-A. Reimer: Effect of beta-adrenergic blockade on acute myocardial ischaemic injury, in Gross (ed.) Modulation of Sympathetic Tone in the Treatment of Cardiovascular diseases. Huber Publishers (Bern 1978).
Reimer, K. A., M. M. Rasmussen, R. B. Jennings: Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circ. Res.33, 353 (1973).
Reimer, K. A., M. M. Rasmussen, R. B. Jennings: On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs. Am. J. Cardiol.37, 520 (1976).
Peter, T., M. K. Heng, B. N. Singh, P. Ambler, H. Nisbet, T. Elliot, R. M. Norris: Failure of high dosis of propranolol to reduce experimental myocardial ischemic damage. Circulation57, 543 (1978).
Winkler, B., J. Mulch, W. Flameng, W. Schaper: Prediction of MVO2 from the pressure pulse in acute coronary occlusion and following reflow after aortic crossclamping. Pflügers Arch. Ger. Physiol.368, R-18 (1977).
Rudolph, A. M., M. A. Heyman: The circulation of the fetus in utero: Methods for studying distribution of blood flow, cardiac output and organ blood flow. Circ. Res.21, 163 (1967).
Pitt, B., P. Craven: Effect of propranolol on regional myocardial blood flow in acute ischaemia. Cardiovasc. Res.4, 176 (1970).
Lowe, J. E., K. A. Reimer, R. B. Jennings: Experimental infarct size as a function of the amount of myocardium at risk. Am. J. Path. Vol.90, No. 2, 363 (1978).
Ichihara, K., M. Ichihara, Y. Abiko: Possible role of beta-adrenergic receptors in myocardial metabolic response to ischemia. In: Winbury, M. M. and Y. Abiko (Eds.) Ischemic Myocardium and Antianginal Drugs, Raven Press (New York 1979).
Author information
Authors and Affiliations
Additional information
With 1 table
Rights and permissions
About this article
Cite this article
Genth, K., Hofmann, M., Hofmann, M. et al. The effect of β-adrenergic blockade on infarct size following experimental coronary occlusion. Basic Res Cardiol 76, 144–151 (1981). https://doi.org/10.1007/BF01907953
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01907953